–SulfoBiotics– GYY4137

• 取扱説明書 日本語
  
• 取扱説明書 English
  
• プロトコル
  

1) L. Li, M. Whiteman, Y. Y. Guan, K. L. Neo, Y. Cheng, S. W. Lee, Y. Zhao, R. Baskar, C-H. Tan, and P. K. Moore, “Characterization of a Novel, Water-Soluble Hydrogen Sulfide-Releasing Molecule (GYY4137): New Insights Into the Biology of Hydrogen Sulfide”, Circulation, 2008, 117, 2351.
2) M. Whiteman, L. Li, P. Rose, C-H. Tan, D. B. Parkinson, and P. K. Moore, “The Effect of Hydrogen Sulfide Donors of Lipopolysaccharide-Induced Formation of Inflammatory Mediators in Macrophages”, Antioxid. Redox Signal., 2013, 19, 1749.
3) Z. W. Lee, J. Zhou, C-S. Chen, Y. Zhao, C-H. Tan, L. Li, P. K. Moore, and L-W. Deng, “The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo”, PLos One, 2011, 6, e21077.
4) L. Li, B. Fox, J. Keeble, M. Salto-Tellez, P. G. Winyard, M. E. Wood, P. K. Moore, and M. Whiteman, “The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells”, J. Cell. Mol. Med., 2013, 17, 365.
5) Z. Liu, Y. Han, L. Li, G. Meng, X. Li, M. Shirhan, M. T. Peh, L. Xie, S. Zhou, X. Wang, Q. Chen, W. Dai, C-H. Tan, S. Pan, P. K. Moore and Y. Ji, “The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E-/- mice”, Br. J. Pharmacology, 2013, 169, 1795.
6) Satoru Sakuma, Saaya Minamino, MayaTakase, Yoshitaka Ishiyama, Hiroyuki Hosokura, Tetsuya Kohda, Yukino Ikeda, Yohko Fujimoto, "Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death", Heliyon., 2019,doi.org/10.1016/j.heliyon.2019.e02244 .